Literature DB >> 2283362

Promotion of transendothelial neutrophil passage by human thrombin.

R Moser1, P Groscurth, J Fehr.   

Abstract

Thrombin has been reported to elicit two temporally different effects on neutrophil-endothelial interaction, categorically described as 'neutrophil adhesion': one expressed within a few minutes, the other after several hours of endothelial preincubation. Prolonged activation resulted in often elongated, tightly interacting neutrophils in contact with human umbilical vein endothelial cells (HUVE) mainly at the intercellular region. In contrast, the neutrophil-endothelial interaction due to short-time priming with thrombin was dominated by round, randomly distributed neutrophils, loosely adhering on the endothelial surface. Sheer stress, introduced to characterize these morphological entities in a quantitative manner, clearly defined the neutrophil response due to short time priming as sheer stresslabile compared to the sheer stress-resistant interaction expressed after prolonged preincubation of HUVE with thrombin. Quantitative determination of neutrophil transendothelial migration served to demonstrate the relevance of such differences in neutrophil binding with respect to subsequent layer penetration. Dependent upon endothelial protein synthesis and inhibited by antithrombin-III-heparin and hirudin, neutrophil layer penetration only occurred after prolonged activation of HUVE whereas the neutrophil-endothelial interaction due to short time priming with thrombin was limited to superficial neutrophil adhesion. We conclude that thrombin can be added to the list of activators capable of inducing the neutrophil passage-guiding principle, an effect that has recently been detected as closely related to neutrophil adhesion to endothelial ligands expressed upon activation with interleukin-1 and tumor necrosis factor. This biological activity, which can be separated from superficial attachment of polymorphonuclear leukocytes (PMN) to endothelial cells, is a catalytic site-dependent and late phase-specific effect of thrombin on HUVE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283362     DOI: 10.1242/jcs.96.4.737

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

Review 1.  Radiation as a risk factor for cardiovascular disease.

Authors:  John E Baker; John E Moulder; John W Hopewell
Journal:  Antioxid Redox Signal       Date:  2011-03-23       Impact factor: 8.401

2.  Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.

Authors:  L de Garavilla; N Vergnolle; S H Young; H Ennes; M Steinhoff; V S Ossovskaya; M R D'Andrea; E A Mayer; J L Wallace; M D Hollenberg; P Andrade-Gordon; N W Bunnett
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.

Authors:  I Vollenweider; R Moser; P Groscurth
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

4.  RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin.

Authors:  Li Qin Zhang; Dilyara Cheranova; Margaret Gibson; Shinghua Ding; Daniel P Heruth; Deyu Fang; Shui Qing Ye
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 5.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31

6.  Thrombin functions as an inflammatory mediator through activation of its receptor.

Authors:  G Cirino; C Cicala; M R Bucci; L Sorrentino; J M Maraganore; S R Stone
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.